Thyroid Disease in Pregnancy: ACOG Practice Bulletin, Number 223 : Obstetrics & Gynecology

Secondary Logo

Journal Logo

Online ACOG Publications

Thyroid Disease in Pregnancy

ACOG Practice Bulletin, Number 223

Author Information
Obstetrics & Gynecology 135(6):p e261-e274, June 2020. | DOI: 10.1097/AOG.0000000000003893


Both thyrotoxicosis and hypothyroidism are associated with adverse pregnancy outcomes. There also is concern about the effect of overt maternal thyroid disease on fetal development. In addition, medications that affect the maternal thyroid gland can cross the placenta and affect the fetal thyroid gland. This document reviews the thyroid-related pathophysiologic changes that occur during pregnancy and the effects of overt and subclinical maternal thyroid disease on maternal and fetal outcomes. This Practice Bulletin has been updated with information on the diagnosis and the management of thyroid disease in pregnant women and includes a new clinical algorithm on management of thyroid disease in pregnancy.

© 2020 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid